secwatch.observer — SEC 8-K summary
======================================

Issuer:     COMPASS Pathways plc (CMPS)
CIK:        0001816590
Form:       8-K
Filed at:   2023-12-07T23:59:59+00:00
Accession:  0001816590-23-000142
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Compass Pathways appoints Teri Loxam as CFO effective March 1, 2024
-------------------------------------------------------------------

- Teri Loxam appointed CFO effective March 1, 2024 or filing of 2023 annual report; advisory role until then.
- Compensation: base salary $490,000, target bonus 45%, initial equity awards totaling $1.8M (60% options, 40% RSUs).
- Loxam has >20 years pharma/biotech experience, including CFO at Gameto, Kira, SQZ Biotech; senior IR at Merck, BMS, IMAX.
- Mary-Rose Hughes continues as interim CFO until Effective Date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816590/000181659023000142/0001816590-23-000142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816590/000181659023000142/cmps-20231205.htm
  HTML page:      https://secwatch.observer/filing/0001816590-23-000142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer